Shanghai, China

Wenyan Luo

This inventor holds 1 USPTO granted patent. Top assignee: Sph No. 1 Biochemical & Pharmaceutical Co., Ltd.. Active years: 2022.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Wenyan Luo

Wenyan Luo is a notable inventor based in Shanghai, China. He has made significant contributions to the field of biochemistry and pharmaceuticals. His work has led to the development of innovative solutions that have the potential to impact various medical applications.

Latest Patents

Wenyan Luo holds a patent for a polymyxin B component or salt thereof, along with its preparation and application. This patent describes a polymyxin B component that includes six α,γ-diaminobutyric acids at specific positions, two threonine residues, a phenylalanine residue, and a leucine residue linked in sequence. The threonine residue at position 10 is connected to the α,γ-diaminobutyric acid at position 4 by an amido bond, while the α,γ-diaminobutyric acid at position 1 is linked to 6-methyloctyl-2-enoyl. This innovative formulation showcases his expertise in biochemical research.

Career Highlights

Wenyan Luo is currently employed at Sph No. 1 Biochemical & Pharmaceutical Co., Ltd. His role at the company allows him to further explore his research interests and contribute to the development of new pharmaceutical products. His dedication to innovation in the field has earned him recognition among his peers.

Collaborations

Wenyan collaborates with talented individuals such as Hanzhi Zhang and Hao Liu. Their teamwork fosters a creative environment that encourages the exchange of ideas and enhances the research process.

Conclusion

Wenyan Luo's contributions to the field of biochemistry and pharmaceuticals are noteworthy. His patent for a polymyxin B component exemplifies his innovative spirit and commitment to advancing medical science. His work continues to inspire future developments in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…